Literature DB >> 20103969

Upregulation of monocyte tissue factor activity is significantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome.

Akihiro Nakagomi1, Mihoko Sasaki, Youhei Ishikawa, Masako Morikawa, Toshiyuki Shibui, Yoshiki Kusama, Hirotsugu Atarashi, Kyoichi Mizuno.   

Abstract

BACKGROUND: The metabolic syndrome (MetS) is a cluster of cardiovascular risk factors closely linked to inflammation and insulin resistance (IR). Tissue factor (TF) is an initiator of the extrinsic coagulation cascade and is expressed on peripheral blood monocytes and macrophages in atherosclerotic plaques. Monocytes are the principle cells capable of TF synthesis. Therefore, TF plays an important role in both thrombosis and atherosclerosis. Elevated levels of lipopolysaccharide (LPS), a strong stimulator of TF, have been observed in patients with MetS. No study has investigated the relationship between monocyte TF activity and inflammation, and IR in MetS. METHODS AND
RESULTS: Peripheral blood mononuclear cells (PBMCs) were collected from 40 normal subjects and 77 patients with MetS. Mononuclear cell TF procoagulant activity (MPCA) was measured with and without 100 pg/ml LPS stimulation using a 1-stage clotting assay and expressed as the mean +/- SD (mU TF/10(6) PBMCs). MPCA in MetS was significantly greater than in normal subjects (without LPS: 88.0+/-74.8 vs 52.6+/-9.8 mU TF/10(6) PBMCs, P<0.001; with LPS: 269.6+/-165.6 vs 158.6+/-42.8 mU TF/10(6) PBMCs, P<0.001). The LPS-stimulated log MPCA in MetS patients was significantly associated with homeostasis model assessment of IR (r=0.256, P=0.024) and log high-sensitivity C-reactive protein (r=0.332, P=0.003).
CONCLUSIONS: Upregulation of monocyte TF is significantly associated with low-grade inflammation and IR in MetS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103969     DOI: 10.1253/circj.cj-09-0835

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli.

Authors:  Hui Wang; James C Paton; Cheleste M Thorpe; Claudine S Bonder; Wai Yan Sun; Adrienne W Paton
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

3.  Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.

Authors:  Karen M Kassel; A Phillip Owens; Cheryl E Rockwell; Bradley P Sullivan; Ruipeng Wang; Ossama Tawfik; Guodong Li; Grace L Guo; Nigel Mackman; James P Luyendyk
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

4.  The association of Helicobacter Pylori infection with dyslipidaemia and other atherogenic factors in dyspeptic patients at St. Paul's Hospital Millennium Medical College.

Authors:  Mujahid Hashim; Ousman Mohammed; Tatek G/Egzeabeher; Mistire Wolde
Journal:  Heliyon       Date:  2022-05-14

5.  Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.

Authors:  Brian J Miller; Andrew Mellor; Peter Buckley
Journal:  Brain Behav Immun       Date:  2012-09-11       Impact factor: 7.217

6.  Increased toll-like receptor activity in patients with metabolic syndrome.

Authors:  Ishwarlal Jialal; Beverley A Huet; Harmeet Kaur; Alexander Chien; Sridevi Devaraj
Journal:  Diabetes Care       Date:  2012-02-22       Impact factor: 19.112

Review 7.  Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions.

Authors:  Shireen Mohammad; Christoph Thiemermann
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.